- Home
- NVAX vs QNST Comparison
NVAX vs QNST Comparison
Compare NVAX & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- QNST
- Stock Information
- Founded
- NVAX 1987
- QNST 1999
- Country
- NVAX United States
- QNST United States
- Employees
- NVAX N/A
- QNST N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- QNST Business Services
- Sector
- NVAX Health Care
- QNST Consumer Discretionary
- Exchange
- NVAX Nasdaq
- QNST Nasdaq
- Market Cap
- NVAX 1.4B
- QNST 1.3B
- IPO Year
- NVAX 1995
- QNST 2010
- Fundamental
- Price
- NVAX $8.38
- QNST $24.77
- Analyst Decision
- NVAX Buy
- QNST Strong Buy
- Analyst Count
- NVAX 6
- QNST 6
- Target Price
- NVAX $17.83
- QNST $28.17
- AVG Volume (30 Days)
- NVAX 4.8M
- QNST 435.5K
- Earning Date
- NVAX 02-26-2025
- QNST 02-06-2025
- Dividend Yield
- NVAX N/A
- QNST N/A
- EPS Growth
- NVAX N/A
- QNST N/A
- EPS
- NVAX N/A
- QNST N/A
- Revenue
- NVAX $885,193,000.00
- QNST $768,810,000.00
- Revenue This Year
- NVAX N/A
- QNST $66.42
- Revenue Next Year
- NVAX N/A
- QNST $9.01
- P/E Ratio
- NVAX N/A
- QNST N/A
- Revenue Growth
- NVAX N/A
- QNST 37.05
- 52 Week Low
- NVAX $3.60
- QNST $12.41
- 52 Week High
- NVAX $23.86
- QNST $26.27
- Technical
- Relative Strength Index (RSI)
- NVAX 45.04
- QNST 63.34
- Support Level
- NVAX $8.30
- QNST $22.45
- Resistance Level
- NVAX $9.77
- QNST $24.59
- Average True Range (ATR)
- NVAX 0.56
- QNST 1.04
- MACD
- NVAX -0.06
- QNST 0.21
- Stochastic Oscillator
- NVAX 12.67
- QNST 94.22
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.